Shares of Shougang Lanza (02553.HK) surged more than 30% on its second day of trading, marking a near 90% increase from its IPO price of HK$14.6.

At the time of writing, the stock was up 30.39% to HK$27.46, with a turnover of HK$85.34 million.

The company is a deep player in the Carbon Capture, Utilization, and Storage (CCUS) industry, focusing on using carbon-rich industrial off-gas from steel and ferroalloy plants as feedstock to produce low-carbon products like ethanol and microbial protein through carbon capture and utilization technologies, while also providing comprehensive low-carbon solutions.

Currently, the firm has established four production plants across Hebei, Ningxia, and Guizhou, with a combined annual capacity of 210,000 tons of ethanol and 23,200 tons of microbial protein.

According to Frost & Sullivan data, based on 2025 figures, Shougang Lanza is the largest company globally in the CCUS sector utilizing synthetic biology technology.

Notably, during its initial public offering, the company's solid fundamentals and high growth prospects garnered strong investor recognition and enthusiastic subscription, with the public offering portion being oversubscribed by approximately 1,421.54 times.

Analysts point out the company's early-mover advantage in the CCUS industry, citing its mature commercial application of synthetic biology technology, its successful development of two major commercial products that have secured a stable global clientele due to their distinct sustainable and low-carbon environmental attributes, and its gas fermentation technology, which has enabled the establishment of an integrated R&D platform from strain selection to industrial application, facilitating a continuous advancement from first-generation carbon reduction to second-generation carbon-negative technologies.